Accessibility Menu
Olympus logo

Olympus(OTC) OLYMY

Market Cap$14.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+506%
5 Year-38%
1 Year+6%
1 Month+18%
$12.85
+9.57%
+1.12Today
Olympus last closing stock price
MetricPriceDate
Last closeUSD 12.852026-08-07
Olympus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+12.94%USD 11.382026-07-31
1 month+18.24%USD 10.872026-07-08
3 month+27.89%USD 10.052026-05-08
Year to date+1.44%USD 12.672025-12-31
1 year+6.04%USD 12.122025-08-07
3 year-18.45%USD 15.762023-08-08
5 year-37.66%USD 20.622021-08-06
Since inception+506.29%USD 2.121995-09-28

Olympus Financials at a Glance

Market Cap

$14.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥1.02T

Net Income (TTM)

¥68.86B

EPS (TTM)

$0.40

P/E Ratio

31.73

Dividend

$0.19

Beta (Volatility)

0.55 (Low)

Price

$12.85

Volume

29,527

Open

$12.10

Previous Close

$12.85

Daily Range

$12.10 - $12.89

52-Week Range

$8.08 - $13.73

Estimated Earnings Date

Aug 7, 2026

OLYMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Olympus

Olympus Corporation is a global leader in the development and distribution of medical equipment, with a strong presence in Japan, the Americas, the Middle East, Asia, and Oceania. The company operates through three primary divisions: Endoscopic Solutions, Therapeutic Solutions, and Other business segments, offering a diverse range of advanced medical technologies.

Products and Services
  • Advanced gastrointestinal endoscopy systems with video and ultrasound technologies
  • Comprehensive endoscopic ecosystem solutions featuring AI-driven insights
  • Respiratory care devices and surgical endoscopy systems for various medical applications
Growth Outlook
  • Revenue increased to 300.7 billion JPY in Q4 2026, reflecting strong demand
  • Operating income margin improved to 18.1% in the latest quarter
  • Continued investment in R&D, with 29.9 billion JPY allocated in Q4 2026
Financial Highlights
  • Net income reached 25.3 billion JPY in Q4 2026, up from 14.4 billion JPY in Q3 2026
  • Gross profit margin stood at 65.3% for the trailing twelve months
  • Dividend yield of 1.71% reflects commitment to returning value to shareholders
Olympus Corporation has established itself as a key player in the medical devices industry, focusing on innovative solutions that enhance patient care. The company's recent financial performance indicates a robust growth trajectory, with significant increases in revenue and net income. The commitment to research and development positions Olympus well for future advancements in medical technology. With a solid gross profit margin and a consistent dividend yield, Olympus Corporation presents an attractive opportunity for potential investors interested in the healthcare sector.
AI Generated • Jul 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

28,138

CEO

Robert White, MBA

Website

www.olympus.co.jp

Headquarters

Hachioji, TY 192-8507, JP

OLYMY Financials

Key Financial Metrics (TTM)

Gross Margin

64.70%

Operating Margin

15.88%

Net Income Margin

7.49%

Return on Equity

10.21%

Return on Capital

9.59%

Return on Assets

5.13%

Earnings Yield

3.15%

Dividend Yield

1.46%

Payout Ratio

42.20%

Stock Overview

Market Cap

$14.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.10B

Volume

29.53K

Avg. Volume

68.39K

Financials (TTM)

Gross Profit

¥660.30B

Operating Income

¥136.81B

EBITDA

¥191.52B

Operating Cash Flow

¥104.72B

Capital Expenditure

-¥55.74B

Free Cash Flow

¥48.98B

Cash & ST Invst.

¥188.85B

Total Debt

¥307.21B

Olympus Performance Analysis

Olympus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 6,510,441,449-2.5%
20242024-03-31JPY 6,410,429,033-1.5%
20252025-03-31JPY 6,542,011,1542.1%
20262026-03-31JPY 6,706,895,0592.5%
Olympus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-22.9%
Q22025-09-3020.3%
Q32025-12-317.2%
Q42026-03-3113.2%
Olympus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.834.0%
20242024-03-31JPY 1.3865.4%
20252025-03-31JPY 0.67-51.2%
20262026-03-31JPY 0.41-39.8%
Olympus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-77.9%
Q22025-09-30127.6%
Q32025-12-31-27.6%
Q42026-03-3171.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

¥300.71B

+12.6%

Gross Profit

¥196.30B

+3.7%

Gross Margin

65.28%

N/A

Market Cap

$14.15BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$502.95K

N/A

Employees

28,138

N/A

Net Income

¥25.27B

-37.9%

EBITDA

¥71.25B

-6.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

¥188.85B

-25.3%

Total Debt

¥307.21B

+5.3%

Accounts Receivable

¥251.17B

+20.4%

Inventory

¥207.99B

+11.1%

Long Term Debt

¥212.51B

+16.4%

Short Term Debt

¥94.70B

-13.2%

Return on Assets

5.13%

N/A

Return on Invested Capital

15.66%

N/A

Free Cash Flow

¥31.42B

-33.6%

Operating Cash Flow

¥42.07B

-32.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ESALYEisai Co., Ltd.
$61.51-2.11%
ODTCOdonate Therapeutics, Inc.
$22,005.00+29.44%
BITGFBiotage AB (publ)
$15.01+0.00%
VTEQVeriTeQ Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About OLYMY

What is the current price of Olympus?

Olympus is trading at $12.85 per share.

What is the 52-week range for Olympus?

Over the past 52 weeks, Olympus has traded between $8.08 and $13.73.

How much debt does Olympus have?

As of the most recent reporting period, Olympus reported total debt of ¥1.92B.

How much cash does Olympus have on hand?

Olympus reported ¥887.53M in cash and cash equivalents in its most recent financial results.

What is Olympus’s dividend yield?

Olympus currently has a dividend yield of 1.46%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services